封面
市場調查報告書
商品編碼
1627640

全球家禽疫苗市場:預測(2025-2030)

Global Poultry Vaccine Market - Forecasts from 2025 to 2030

出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 135 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

全球家禽疫苗市場規模預計將從2025年的2,202,673,000美元增加到2030年的2,698.1百萬美元,複合年成長率為4.14%。

全球家禽生產的快速成長和多種家禽疾病發病率的增加正在推動這個全球市場。隨著對家禽產品的需求增加,人們對食用病禽相關健康風險的認知也隨之增加。這種意識的增強鼓勵家禽製造商定期接種疫苗,對家禽疫苗市場的成長產生了積極影響。

各國政府和國際組織擴大採取措施,透過規範家禽養殖和確保生物安全來降低透過家禽傳播疾病的風險。各國政府實施了嚴格的生物安全法規,實施了疫苗接種計劃等疾病管制計劃,並制定了規範家禽養殖的規則和政策。疫苗接種規則和法規正在推動全球家禽疫苗市場的發展。

市場區隔依疾病類型、產品和地區分類。依疾病類型分為禽流感、馬立克氏症、支氣管炎等。依產品分為去活化疫苗、減毒活病毒疫苗、重組疫苗等。這種細分可以更深入地了解家禽疫苗市場的多樣化需求。

家禽疫苗市場促進因素

  • 由於家禽數量增加,家禽疫苗的需求增加

家禽數量的增加預計將推動家禽疫苗市場的成長。由於消費者比以往任何時候都更喜歡家禽,全球對家禽的需求正在增加。由於其蛋白質營養價值高,對家禽食品的需求不斷成長。隨著世界人口的增加,由於他們的飲食偏好,對雞肉的需求也增加。根據美國糧食及農業組織的數據,肉類產量從 1961 年的 900 萬噸躍升至 2020 年的 1.33 億噸。因此,家禽需求的增加反過來將導致家禽疫苗市場的擴大。

家禽疫苗市場的地理前景:

  • 北美在家禽疫苗市場佔據主要佔有率,預計在預測期內將保持其主導地位

從地區來看,全球市場分為亞太地區、北美、南美、歐洲和中東/非洲。北美佔據家禽疫苗市場的主要佔有率。由於雞肉相關食品的消費增加,該地區的雞肉產量正在增加。這增加了禽類疾病的發生率,引發了人們對家禽食品安全的擔憂,並增加了該地區對家禽疫苗的需求。此外,該地區主要市場參與者的存在也促進了家禽疫苗的成長。

根據聯合國糧食及農業組織(FAO)的數據,美國是最大的禽肉生產國,佔全球產量的17%。根據美國農業部的數據,肉雞以金額為準從 2021 年的 461 億美元增加到 770 億美元。這一巨大的產量也引領北美家禽疫苗市場。

為什麼要購買這份報告?

  • 富有洞察力的分析:獲得涵蓋主要和新興地區的深入市場洞察,重點關注客戶細分、政府政策和社會經濟因素、消費者偏好、行業和其他子區隔。
  • 競爭格局:了解世界主要企業採取的策略策略,並了解透過正確的策略滲透市場的潛力。
  • 市場趨勢和促進因素:探索動態因素和關鍵市場趨勢以及它們將如何影響未來的市場發展。
  • 可行的建議:利用洞察力做出策略決策,在動態環境中釋放新的業務流和收益。
  • 受眾廣泛:對於新興企業、研究機構、顧問、中小企業和大型企業有用且具有成本效益。

它有什麼用?

產業和市場考量、機會評估、產品需求預測、打入市場策略、地理擴張、資本投資決策、法律規範與影響、新產品開發、競爭影響。

調查範圍

  • 2022年至2030年的實際資料和預測
  • 成長機會、挑戰、供應鏈前景、法規結構、顧客行為、趨勢分析
  • 競爭定位、策略和市場佔有率分析
  • 區域收益成長和預測分析,包括細分市場和國家
  • 公司簡介(主要是策略、產品、財務資訊、主要動態等)

目錄

第1章簡介

  • 市場概況
  • 市場定義
  • 調查範圍
  • 市場區隔
  • 貨幣
  • 先決條件
  • 基準年和預測年時間表
  • 相關人員的主要利益

第2章調查方法

  • 研究設計
  • 調查過程

第3章執行摘要

  • 主要發現
  • 分析師觀點

第4章市場動態

  • 市場促進因素
  • 市場限制因素
  • 波特五力分析
  • 產業價值鏈分析

第5章全球家禽疫苗市場:依疾病類型

  • 介紹
  • 禽流感
  • 馬立克氏症
  • 支氣管炎
  • 其他

第6章全球家禽疫苗市場:依產品

  • 介紹
  • 去活化疫苗
  • 減毒活病毒疫苗
  • 重組疫苗
  • 其他

第7章全球家禽疫苗市場:依地區

  • 介紹
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 其他
  • 中東/非洲
    • 沙烏地阿拉伯
    • 以色列
    • 其他
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 韓國
    • 印尼
    • 泰國
    • 其他

第8章競爭環境及分析

  • 主要企業及策略分析
  • 市場佔有率分析
  • 併購/協議/合作
  • 競爭對手儀表板

第9章 公司簡介

  • Zoetis Inc.
  • Boehringer Ingelheim International GmbH
  • Ceva Sante Animale
  • Merck & Co. Inc.(Merck Animal Health)
  • AniCon Labor GmbH
  • Hester Biosciences Limited
  • Elanco Animal Health Incorporated
  • Biovac SA
  • Phibro Animal Health Corporation
  • Salfarm Danmark A/S
簡介目錄
Product Code: KSI061613992

The global poultry vaccine market is expected to grow at a CAGR of 4.14%, reaching a market size of US$2,698.1 million in 2030 from US$2,202.673 million in 2025

The rapidly growing poultry production worldwide and the growing incidence of several poultry diseases are driving this global market. As the demand for poultry products increases, so does the awareness of the health risks associated with consuming diseased poultry. This heightened awareness is prompting poultry manufacturers to regularly vaccinate their flocks, positively influencing the global poultry vaccine market growth.

National governments and international organizations are increasingly taking steps to reduce the risk of disease transmission due to poultry animals by regulating poultry farming and ensuring biosecurity. Governments are implementing strict biosecurity regulations, taking up disease control programs like vaccination programs, and framing rules and policies to regulate poultry farming. The rules and regulations regarding vaccination are increasing the market for global poultry vaccines.

The global poultry vaccine market has been segmented by disease type, product, and geography. By disease type, it is classified as avian influenza, Marek's Disease, bronchitis, and others. It is segmented based on products such as inactivated vaccines, attenuated live vaccines, recombinant vaccines, and others. This segmentation allows for a better understanding of diverse needs within the global poultry vaccine market.

Global Poultry Vaccine Market Drivers

  • Growing poultry population is increasing the demand for poultry vaccines

The growing poultry population is anticipated to lead the market growth of poultry vaccines. The demand for poultry is growing globally as consumers prefer more of it in their diet than earlier. Due to its high nutritional value in terms of protein, the demand for poultry food is growing. As the global population grows, the demand for poultry due to their diet preference also increases. As per the Food and Agriculture Organization of the United States, meat production has soared from 9 million tonnes in 1961 to 133 million tonnes in 2020. Thus, the growing demand for poultry, in turn, would lead to an increase in the market for poultry vaccines.

Global Poultry Vaccine Market Geographical Outlook:

  • North America holds a significant market share in global poultry vaccine and will continue to dominate in the forecast period

Region-wise, the global market is segmented into Asia-Pacific, North America, South America, Europe, Middle East and Africa. North America accounted for a significant share of the global poultry vaccine market. Increasing consumption of poultry-related food products has boosted poultry production in the region. This has led to concerns about the safety of poultry food products due to the rising incidence of avian diseases, augmenting the demand for poultry vaccines in the region. Moreover, the presence of major market players in the region is contributing to the poultry vaccine's growth.

According to the United Nations Food and Agriculture Organization (FAO), the United States is the largest producer of poultry meat, holding 17% of the global output. As per USDA, the total production of broilers in terms of value has increased from $46.1 billion in 2021 to $77.0 billion. This significant production is also leading North America in the poultry vaccine market.

Reasons for buying this report:-

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, other sub- segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape up future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decision to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data & forecasts from 2022 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, Customer Behaviour, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others)

Global Poultry Vaccine market is segmented and analyzed as follows:

By Disease Type

  • Avian Influenza
  • Marek's Diseases
  • Bronchitis
  • Others

By Product

  • Inactivated Vaccines
  • Attenuated Live Vaccines
  • Recombinant Vaccines
  • Others

By Geography

  • North America
  • United States
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • UK
  • Germany
  • France
  • Italy
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • Israel
  • Others
  • Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Indonesia
  • Thailand
  • Others

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. Market Overview
  • 1.2. Market Definition
  • 1.3. Scope of the Study
  • 1.4. Market Segmentation
  • 1.5. Currency
  • 1.6. Assumptions
  • 1.7. Base and Forecast Years Timeline
  • 1.8. Key Benefits for the Stakeholders

2. RESEARCH METHODOLOGY

  • 2.1. Research Design
  • 2.2. Research Process

3. EXECUTIVE SUMMARY

  • 3.1. Key Findings
  • 3.2. Analyst View

4. MARKET DYNAMICS

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Supplier
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. The Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis

5. GLOBAL POULTRY VACCINE MARKET BY DISEASE TYPE

  • 5.1. Introduction
  • 5.2. Avian Influenza
  • 5.3. Marek's Diseases
  • 5.4. Bronchitis
  • 5.5. Others

6. GLOBAL POULTRY VACCINE MARKET BY PRODUCT

  • 6.1. Introduction
  • 6.2. Inactivated Vaccines
  • 6.3. Attenuated Live Vaccines
  • 6.4. Recombinant Vaccines
  • 6.5. Others

7. GLOBAL POULTRY VACCINE MARKET BY GEOGRAPHY

  • 7.1. Introduction
  • 7.2. North America
    • 7.2.1. United States
    • 7.2.2. Canada
    • 7.2.3. Mexico
  • 7.3. South America
    • 7.3.1. Brazil
    • 7.3.2. Argentina
    • 7.3.3. Others
  • 7.4. Europe
    • 7.4.1. UK
    • 7.4.2. Germany
    • 7.4.3. France
    • 7.4.4. Italy
    • 7.4.5. Others
  • 7.5. Middle East and Africa
    • 7.5.1. Saudi Arabia
    • 7.5.2. Israel
    • 7.5.3. Others
  • 7.6. Asia Pacific
    • 7.6.1. Japan
    • 7.6.2. China
    • 7.6.3. India
    • 7.6.4. South Korea
    • 7.6.5. Indonesia
    • 7.6.6. Thailand
    • 7.6.7. Others

8. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 8.1. Major Players and Strategy Analysis
  • 8.2. Market Share Analysis
  • 8.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 8.4. Competitive Dashboard

9. COMPANY PROFILES

  • 9.1. Zoetis Inc.
  • 9.2. Boehringer Ingelheim International GmbH
  • 9.3. Ceva Sante Animale
  • 9.4. Merck & Co. Inc. (Merck Animal Health)
  • 9.5. AniCon Labor GmbH
  • 9.6. Hester Biosciences Limited
  • 9.7. Elanco Animal Health Incorporated
  • 9.8. Biovac S.A.
  • 9.9. Phibro Animal Health Corporation
  • 9.10. Salfarm Danmark A/S